Deep Dive Into CVS Health Stock: Analyst Perspectives (15 Ratings)
Portfolio Pulse from Benzinga Insights
Over the past three months, 15 analysts have shared their insights on CVS Health (NYSE:CVS), with a mix of bullish to bearish opinions. The average 12-month price target has dropped 21.7% to $66.13. Analysts have frequently lowered their ratings and price targets, reflecting a cautious outlook on CVS Health's stock.
July 23, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have mixed views on CVS Health, with a significant drop in the average 12-month price target to $66.13, reflecting a cautious outlook. Recent ratings show a trend of lowering price targets and ratings.
The significant drop in the average 12-month price target and the trend of analysts lowering their ratings and price targets indicate a cautious outlook on CVS Health's stock. This is likely to have a negative short-term impact on the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100